JCOG

The Japan Clinical Oncology Group (JCOG) is the largest Japanese cooperative group funded primarily by the National Cancer Center Research and Development Fund.

RTSG:Radiation Therapy Study Group / Publications

更新日:2013年11月8日

a. 論文

1. 委員会承認の治療研究

なし  

2. グループ代表者管理の治療研究

Y Nagata, et al.: Clinical outcomes of a Phase I/II study of 48Gy of stereotactic body radiation therapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys. 63(5) : 1427-1431, 2005.

3. 附随研究等

関 智史、MD Hossain、国枝 悦夫、他:異なる施設間での肺小腫瘤GTVの解析. 日放腫会誌. 17:25-30, 2005.
T Nishio, E Kunieda, H Shirato, et al.: Dosimetric verification in participating institutions in a stereotactic body radiotherapy trial for stage I non-small cell lung cancer: Japan Clinical Oncology Group trial (JCOG0403). Phys Med Biol. 51: 5409-5417, 2006.
Y Matsuo, K Takayama, Y Nagata, et al.: Interinstitutional Variations in Planning for Stereotactic Body Radiation Therapy for Lung Cancer. Int J Radiat Oncol Biol Phys. 68:416-425, 2007.
T Toita, M Oguchi, T Kodaira, et al.: Quality assurance in the prospective multi-institutional trial on definitive radiotherapy using high-dose-rate intracavitary brachytherapy for uterine cervical cancer. The individual case review. Jpn J Clin Oncol. 39(12):813-819, 2009.
M Yamaguchi, M Oguchi, S Ishikura, et al.: Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211. J Clin Oncol. 27:5594-5600, 2009.
N Sanuki-Fujimoto, S Ishikura, K Hayakawa, et al.: Radiotherapy quality assurance review in a multi-center randomized trial of limited-disease small cell lung cancer: the Japan Clinical Oncology Group (JCOG) trial 0202. Radiation Oncology. 4:16, 2009.
Y Nishimura, T Shibata, K Nakamatsu, et al.: A two-step intensity modulated radiation therapy method for nasopharyngeal cancer: The Kinki University experience. Jpn J Clin Oncol. 40:130-138, 2010.
T Toita, T Ohno, Y Kaneyasu, et al.: A consensus-based guideline defining the clinical target volume for pelvic lymph nodes in external beam radiotherapy for uterine cervical cancer. Jpn J Clin Oncol. 40:456-463, 2010.
T Toita, T Ohno, Y Kaneyasu, et al.: A consensus-based guideline defining clinical target volume (CTV) for primary disease in external beam radiotherapy for intact uterine cervical cancer. Jpn J Clin Oncol. 41:1119-1126, 2011.
T Toita, S Kato, Y Niibe, et al.: Prospective Multi-Institutional Study of Definitive Radiotherapy With High-Dose-Rate Intracavitary Brachytherapy in Patients With Nonbulky (<4-cm) Stage I and II Uterine Cervical Cancer (JAROG0401/JROSG04-2). Int J Radiat Oncol Biol Phys. 82:e49-56, 2012.
N Sanuki, S Ishikura, M Shinoda, et al.: Radiotherapy quality assurance review for a multi-center randomized trial of locally advanced esophageal cancer: the Japan Clinical Oncology Group (JCOG) trial 0303. Int J Clin Oncol. 17:105-111, 2012.
M Nozaki, Y Kagami, M Mitsumori, et al.: A multiple investigation of Late adverse events in Japanese women treated with breast-conserving surgery plus conventional fractionated whole-breast radiation therapy. Jpn J Clin Oncol. 42:522-527, 2012.
G Kasuya, T Toita, K Furutani, et al.: Distribution patterns of metastatic pelvic lymph nodes assessed by CT/MRI in patients with uterine cervical cancer. Radiat Oncol. 8:139, 2013.

4. 総説・解説

佐野尚樹、佐々木潤一、西尾禎治、他:体幹部定位放射線治療「ガイドラインの詳細とマニュアル」 大西 洋、平岡真寛 編著. 中外医学社. 2006.
M Hiraoka, S Ishikura: A Japan Clinical Oncology Group Trial for Stereotactic Body Radiation Therapy of Non-Small Cell Lung Cancer. J Thorac Oncol. 2(7): S115-117, 2007.
K Nakamura, T Kodaira, N Shikama, et al.: Accelerated fractionation versus conventional fractionation radiation therapy for glottic cancer of T1-2N0M0 Phase III study Japan Clinical Oncology Group study (JCOG 0701). Jpn J Clin Oncol. 38:387-389, 2008.
S Ishikura: Quality assurance of radiotherapy in cancer treatment: Toward improvement of patient safety and quality of care. Jpn J Clin Oncol. 38:723-729, 2008.
石倉聡:SRTは外科手術に替わりうるか?EBMがん化学療法・分子標的治療法.西條長宏監修.中外医学社.179-181, 2010.
Y Nagata, J Wulf, I Lax, et al.: Stereotactic radiotherapy of primary lung cancer and other targets. Results of consultant meeting of the International Atomic Energy Agency (IAEA). Int J Radiat Oncol Biol Phys. 79(3):660-669, 2010.
S Ishikura, Y Ito, M Hiraoka: JCOG Radiation Therapy Study Group: History and achievements. Jpn J Clin Oncol. 41:1241-1243, 2011.

b. 主な学会発表

1. 委員会承認の治療研究

Y Nagata, M Hiraoka, T Shibata, et al.: A phase II Trial of Stereotactic Body Radiation Therapy for Operable T1N0M0 Non-Small Cell Lung Cancer, Japan Clinical Oncology Group (JCOG0403). The 52nd ASTRO Annuall Meeting, Oct 2010.
M Hiraoka, Y Nagata, T Shibata, et al.: Results of a Phase II Study of Stereotactic Body Radiation Therapy for Operable T1N0M0 Non-Small Cell Lung Cancer by Japan Clinical Oncology Group (JCOG0403). 2010 Chicago Multidisciplinary Symposium in Thoracic Oncology, Dec 2010.
Y Nagata, M Hiraoka, T Shibata, et al.: Stereotactic body radiation therapy for inoperable T1N0M0 non-small cell lung cancer: Analysis of the Japan Clinical Oncology Group study (JCOG0403). The 54th ASTRO Annual Meeting, Oct 2012.

2. グループ代表者管理の治療研究

なし  

3. 附随研究等

T Nishio, M Shimbo, E Kunieda, et al.: Quality assurance of radiotherapy treatment planning system prior to stereotactic irradiation for lung tumor trial : Japan Clinical Oncology Group (JCOG) study. The 23th ESTRO Meeting. Oct 2004.
Y Matsuo, K Takayama, Y Nagata, et al.: Results of Institutional Differences in Treatment Planning for a Multi-institutional Trial of Stereotactic Radiotherapy for T1N0M0 Lung Cancer (JCOG0403). The 47th ASTRO Annual Meeting. Oct 2005.
M Oguchi, Y Kagami, S Ishikura, et al.: Upfront radiotherapy with concurrent chemotherapy for localized nasal NK/T-cell lymphoma: Radiotherapy quality assurance (QA) review in Japan Clinical Oncology Group (JCOG) trial 0211. The 50th ASTRO Annual Meeting. Sep 2008.
S Ishikura, M Hiraoka, W Bosch, et al.:Radiotherapy quality assurance (QA) in a multi-center stereotactic body radiation therapy (SBRT) trial for stage IA non-small cell lung cancer: The Japan Clinical Oncology Group (JCOG) trial 0403. Fourth International Conference on Translational Research and Pre-Clinical Strategies in Radiation Oncology (ICTR). Mar 2009.
西尾禎治、石川正純、小澤修一、他:水タンク式肺ファントムを利用した治療計画装置の線量計算精度検証.日本医学物理学会第99回学術大会.2010年4月.
野崎美和子、加賀美芳和、光森通英、他: 乳房温存療法の術後標準照射法における遅発性有害事象に関する多施設前向き調査.第23回日本放射線腫瘍学会.2010年10月.
T Toita, T Ohno, Y Kaneyasu, et al.: Clinical target volume (CTV) for primary disease in external beam radiotherapy for intact uterine cervical cancer. The 17th International Meeting of the European Society of Gynaecological Oncology. Sep 2011.
Y Matsuo, S Ishikura, T Shibata, et al. :Dose-Volume Analysis in a Phase II Study of Stereotactic Body Radiation Therapy for cT1N0M0 Non-small Cell Lung Cancer (JCOG0403): Impact of Dose Calculation Algorithm with Heterogeneity Correction on Local Control in Operable Patients. The 53rd ASTRO Annual Meeting. Oct 2011.
石川正純、Sutherland Kenneth、峯村俊行、他:第三者評価におけるGradient法を用いたフィルム線量分布解析の合格基準に関する考察.日本放射線腫瘍学会第25回学術大会.2012年11月.
C Melidis, WR Bosch, J Izewska, et al.: Harmonisation of quality assurance for clinical trials in radiotherapy. The 31st ESTRO Annual Meeting. May 2012.
CW Hurkmans, M Ebert, Y Xiao, et al.: Harmonizing quality assurance procedures and corresponding naming conventions in clinical trials in radiotherapy. The 2nd ESTRO Forum. Apr 2013.
野崎美和子、加賀美芳和、平岡眞寛:寡分割全乳房照射. 第21回日本乳癌学会.2013年6月.

4. 総説・解説

Y Nagata, M Hiraoka: A phase-II study of the stereotactic body radiotherapy for T1N0M0 non-small cell lung cancer. 第10回日本高精度放射線外部照射研究会. 2004年7月.
永田 靖、平岡真寛:JCOG0403 T1N0M0非小細胞肺癌に対する体幹部定位照射.第14回日本定位放射線治療学会. 2005年9月.
M Hiraoka: A JCOG trial for SRT of NSCLC. The 11th International Association for the study of Lung Cancer Workshop. Sep 2006.
石倉聡:臨床試験(JCOG)における放射線治療の品質管理.第44回日本癌治療学会総会、シンポジウム「肺がんの化学療法・放射線療法:現在と未来」. 2006年10月.